Rienk Pypstra
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
Papers in
-
- Antimicrobial Resistance in Staphylococcus 3
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
-
- Pneumonia and Respiratory Infections 2
- Mycobacterium research and diagnosis 1
- Co-authors
- Gary J. Noel (2 shared papers)Joseph S. Solomkin (1 shared paper)Richard Strauß (1 shared paper)M. Heep (1 shared paper)Karen Amsler (1 shared paper)Peter Ball (2 shared papers)Jennifer Hammond (6 shared papers)Thomas P. Lodise (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)New England Journal of Medicine (2 papers)Open Forum Infectious Diseases (2 papers)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Rienk Pypstra
11 papers receiving 388 citations
Rienk Pypstra's Hit Papers
Peers
Comparison fields: 5 of 47
- Molecular Medicine 89
- Infectious Diseases 194
- Clinical Biochemistry 60
- Pharmacology 131
- Applied Microbiology and Biotechnology 14
Countries citing papers authored by Rienk Pypstra
This map shows the geographic impact of Rienk Pypstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rienk Pypstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rienk Pypstra more than expected).
Fields of papers citing papers by Rienk Pypstra
This network shows the impact of papers produced by Rienk Pypstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rienk Pypstra. The network helps show where Rienk Pypstra may publish in the future.
Co-authors
The 25 scholars most cited alongside Rienk Pypstra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 146 | |
| 2 | 2007 | 61 | |
| 3 | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 Hit paper breakdown → | 2024 | 58 |
| 4 | 2002 | 49 | |
| 5 | 2003 | 31 | |
| 6 | 2025 | 14 | |
| 7 | 2018 | 13 | |
| 8 | 2024 | 11 | |
| 9 | 2022 | 6 | |
| 10 | 2024 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2025 | 0 |
About Rienk Pypstra
Rienk Pypstra is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Clinical Biochemistry and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 400 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Pneumonia and Respiratory Infections (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), COVID-19 Clinical Research Studies (1 paper), Mycobacterium research and diagnosis (1 paper), Respiratory and Cough-Related Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Molecular Medicine (89 citations), Infectious Diseases (194 citations), Clinical Biochemistry (60 citations), Pharmacology (131 citations) and Applied Microbiology and Biotechnology (14 citations). Rienk Pypstra has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Gary J. Noel, Joseph S. Solomkin, Richard Strauß, M. Heep, Karen Amsler, Peter Ball, Jennifer Hammond, Thomas P. Lodise, Karen Bush and Hui C. Kimko. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, New England Journal of Medicine, Open Forum Infectious Diseases and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.